ConvaTec Group PLC GentleCath Glide and me+ Launches in Europe
September 19 2017 - 1:01AM
RNS Non-Regulatory
TIDMCTEC
ConvaTec Group PLC
19 September 2017
ConvaTec Introduces GentleCath(TM) Glide and me+(TM) Continence
Care Programme for Intermittent Catheter Users in Europe
-- Hydrophilic catheter with advanced FeelClean(TM) technology
developed to make catheterization simple and convenient for daily
users
-- me+(TM) programme for continence care provides solutions to
help relieve stress of daily catheterisation and provide greater
value for intermittent catheter users
READING, UNITED KINGDOM (19 September 2017) - ConvaTec Group Plc
("ConvaTec"), a leading global medical products and technologies
company, today announced the European introduction of
GentleCath(TM) Glide, an intermittent catheter developed to provide
simple, convenient hydrophilic catheterisation for daily users. The
availability of GentleCath(TM) Glide in European markets follows
its successful launch in the US earlier this year, and will be
supported by the roll out of the me+(TM) programme for continence
care, an extension of the company's direct-to-consumer programme in
ostomy care.
GentleCath(TM) Glide is a low friction hydrophilic intermittent
catheter made with ConvaTec's unique FeelClean(TM) technology that
activates immediately when in contact with water. The FeelClean(TM)
technology was developed to reduce the residuals and mess left
behind by catheterisation, so users can worry less about getting
residue on their clothes, hands and body. GentleCath(TM) Glide also
features a no-touch sleeve to help prevent contamination of the
catheter from the hands.(1-3)
"A high quality, smooth hydrophilic surface is important to
minimize the risk of trauma during intermittent catheterization.
GentleCath(TM) Glide provides my catheter users with a comfortable
and convenient hydrophilic cathing experience," said Brian L.
Cohen, M.D., M.P.H.
"We are very excited to bring our innovative GentleCath(TM)
Glide and me+(TM) care programme for intermittent catheter users to
Europe," said Mads Haugaard, Vice President and General Manager,
Continence & Critical Care. "We will continue to expand our
GentleCath(TM) portfolio to provide greater choice and meet the
needs of all intermittent catheter users. The combination of our
innovative products and services, and our strong distribution
relationships from our Ostomy Care business uniquely positions
ConvaTec to be successful in Continence Care in Europe."
me+(TM) Programme for Intermittent Catheter Users
Created in collaboration with clinicians and intermittent
catheter users for clinicians and intermittent catheter users, the
GentleCath(TM) me+(TM) programme provides a range of resources,
tools and information alongside the professional advice and
personalized support from dedicated wound, ostomy and continence
nurses that is unique to ConvaTec's me+(TM) approach.
The me+(TM) programme for continence care features extensive
web-based resources (www.gentlecath.com), including personalized
video user guides. The innovative user guides provide tips and
guidance on using GentleCath(TM) products that can be customized to
each individual user to ensure they have the most relevant
information as they start catheterisation. The me+(TM) Answers
section, also offers an intelligent video FAQ tool with an advanced
search function to help users find the most relevant answers and
information easily and quickly.
For more information, visit www.convatec.com or
www.gentlecath.com, or call ConvaTec customer service.
About me+(TM) for ostomy and continence care
me+(TM) is a consumer-focused support and service platform
designed to help resolve unmet needs and elevate the experience of
living with an ostomy or continence condition. Through the me+(TM)
programme, ConvaTec provides support through resources, tools,
honest information, emotional support and superior products. By
combining our product offering with a robust service and support
programme, it is our belief that people living with an ostomy or
continence condition are more likely to have good outcomes and a
better experience.
About ConvaTec
ConvaTec is a global medical products and technologies company
focused on therapies for the management of chronic conditions. The
Company is listed on the London Stock Exchange (stock symbol: CTEC)
and has leading market positions in advanced wound care, ostomy
care, continence and critical care, and infusion devices.
ConvaTec's products provide a range of clinical and economic
benefits, including infection prevention, protection of at-risk
skin, improved patient outcomes and reduced total cost of care.
www.convatecgroup.com
# # #
GentleCath and FeelClean are trademarks of Unomedical a/s. me+
is a trademark of ConvaTec Inc.
(c) 2017 ConvaTec Inc.
AP-018237-MM
1. Hudson E. & Murahata R.I. The 'no-touch' method of
intermittent urinary catheter insertion: can it reduce the risk of
bacteria entering the bladder? Spinal Cord 2005;43(10):611-614.
2. Charbonneau-Smith R. No-touch catheterization and infection
rates in a select spinal cord injured population. Rehabilitation
Nursing 1993;18(5):296-299, 305.
3. Cardenas DD, Hoffman JM. Hydrophilic catheters versus
noncoated catheters for reducing the incidence of urinary tract
infections: a randomized controlled trial. Arch Phys Med Rehabil
2009;90(10):1668-71.
This information is provided by RNS
The company news service from the London Stock Exchange
END
NRAUWRORBBAKAAR
(END) Dow Jones Newswires
September 19, 2017 02:01 ET (06:01 GMT)
Convatec (LSE:CTEC)
Historical Stock Chart
From Apr 2024 to May 2024
Convatec (LSE:CTEC)
Historical Stock Chart
From May 2023 to May 2024